UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Combined Loss of the GATA4 and GATA6 Transcription Factors in Male Mice Disrupts Testicular Development and Confers Adrenal-Like Function in the Testes

Endocrinology (Philadelphia), 2015-05, Vol.156 (5), p.1873-1886

2015

Volltextzugriff (PDF)

The transcription factor GATA4 is required for follicular development and normal ovarian function

Developmental biology, 2013-09, Vol.381 (1), p.144-158

2013

Volltextzugriff (PDF)

Simultaneous gene deletion of gata4 and gata6 leads to early disruption of follicular development and germ cell loss in the murine ovary

Biology of reproduction, 2014-07, Vol.91 (1), p.24

2014

Volltextzugriff (PDF)

Molecular Mechanisms of Primary Aldosteronism

Endocrinology and Metabolism, 2019, 34(4), , pp.355-366

2019

Volltextzugriff (PDF)

Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors

Endocrinology (Philadelphia), 2015-07, Vol.156 (7), p.2503-2517

2015

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study

Journal of the American Heart Association, 2024-04, Vol.13 (8), p.e030607

2024

Volltextzugriff (PDF)

Simultaneous Gene Deletion of Gata4 and Gata6 Leads to Early Disruption of Follicular Development and Germ Cell Loss in the Murine Ovary1

Biology of reproduction, 2014-07, Vol.91 (1)

2014

Volltextzugriff (PDF)

LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.346-346

2023

Volltextzugriff (PDF)

Abstract 12690: Mavacamten Treatment in Patients With Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Pooled Safety Analysis of 5 Clinical Trials

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks

Journal of cardiac failure, 2024-01, Vol.30, p.S2-S3

2024

Volltextzugriff (PDF)

96-WEEK CARDIAC MAGNETIC RESONANCE (CMR) RESULTS OF TREATMENT WITH MAVACAMTEN FROM THE EXPLORER COHORT OF THE MAVA-LONG-TERM EXTENSION (LTE) STUDY IN PATIENTS (PTS) WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM)

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.326-326

2023

Volltextzugriff (PDF)

Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

European heart journal, 2024-09

2024

Volltextzugriff (PDF)

Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy

JACC. Heart failure, 2024-01, Vol.12 (1), p.164-177

2024

Volltextzugriff (PDF)

Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort

JACC. Heart failure, 2024-01, Vol.12 (1), p.164-177

2024

Volltextzugriff (PDF)

Molecular Mechanisms of Primary Aldosteronism

Endocrinology and metabolism (Seoul), 2019-12, Vol.34 (4), p.355-366

2019

Volltextzugriff (PDF)

Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled Trial

Movement disorders, 2020-12, Vol.35 (12), p.2250-2260

2020

Volltextzugriff (PDF)

The Scientific Basis for Law as a Public Health Tool

American journal of public health (1971), 2009-01, Vol.99 (1), p.17-24

2009

Volltextzugriff (PDF)

Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region

Molecular therapy, 2009-11, Vol.17 (11), p.1929-1937

2009

Volltextzugriff (PDF)

Participatory research to promote physical activity at congregate-meal sites

Journal of aging and physical activity, 2005-04, Vol.13 (2), p.121

2005

Volltextzugriff (PDF)

Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the [beta]-Globin Locus Control Region

Molecular therapy, 2009-11, Vol.17 (11), p.1929

2009

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined Loss of the GATA4 and GATA6 Transcription Factors in Male Mice Disrupts Testicular Development and Confers Adrenal-Like Function in the Testes

The transcription factor GATA4 is required for follicular development and normal ovarian function

Simultaneous gene deletion of gata4 and gata6 leads to early disruption of follicular development and germ cell loss in the murine ovary

Molecular Mechanisms of Primary Aldosteronism

Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors

Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study

Simultaneous Gene Deletion of Gata4 and Gata6 Leads to Early Disruption of Follicular Development and Germ Cell Loss in the Murine Ovary1

LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY

Abstract 12690: Mavacamten Treatment in Patients With Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Pooled Safety Analysis of 5 Clinical Trials

Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks

96-WEEK CARDIAC MAGNETIC RESONANCE (CMR) RESULTS OF TREATMENT WITH MAVACAMTEN FROM THE EXPLORER COHORT OF THE MAVA-LONG-TERM EXTENSION (LTE) STUDY IN PATIENTS (PTS) WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM)

Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort

Molecular Mechanisms of Primary Aldosteronism

Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled Trial

The Scientific Basis for Law as a Public Health Tool

Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region

Participatory research to promote physical activity at congregate-meal sites

Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the [beta]-Globin Locus Control Region

Aktive Filter

Suchergebnisse filtern